Entropy Technologies, LP Incyte Corp Transaction History

Entropy Technologies, LP

  • $1.03 Trillion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025
BUY
$65.08 - $83.38 $1.52 Million - $1.95 Million
23,337 New
23,337 $1.61 Billion
Q2 2024

Aug 12, 2024
BUY
$51.18 - $63.75 $997,498 - $1.24 Million
19,490 Added 339.55%
25,230 $1.53 Billion
Q1 2024

May 08, 2024
BUY
$56.55 - $66.59 $324,597 - $382,226
5,740 New
5,740 $327 Million

Others Institutions Holding INCY

# of Institutions
730
Shares Held
202M
Call Options Held
516K
Put Options Held
265K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Entropy Technologies, LP Portfolio

Follow Entropy Technologies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Entropy Technologies, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email